{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:48:41Z","timestamp":1794541721915,"version":"4.9.1"},"reference-count":119,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004035","name":"Jordan University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.heliyon.2022.e11010","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T13:29:33Z","timestamp":1665408573000},"page":"e11010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["An update of polycystic ovary syndrome: causes and therapeutics options"],"prefix":"10.1016","volume":"8","author":[{"given":"Abeer M.","family":"Rababa\u2019h","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayan R.","family":"Matani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Yehya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.heliyon.2022.e11010_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11010_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.23736\/S0026-4784.19.04404-6","article-title":"Criteria, phenotypes and prevalence of polycystic ovary syndrome","volume":"71","author":"Belenkaia","year":"2019","journal-title":"Minerva Ginecol."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11010_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ecl.2013.10.003","article-title":"Polycystic ovary syndrome","volume":"43","author":"Nandi","year":"2014","journal-title":"Endocrinol Metab. Clin. N. Am."},{"issue":"11","key":"10.1016\/j.heliyon.2022.e11010_bib4","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1210\/jc.2013-2040","article-title":"Renaming PCOS--a two-state solution","volume":"98","author":"Dunaif","year":"2013","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11010_bib5","first-page":"407","article-title":"Polycystic ovary syndrome","volume":"53","author":"Meier","year":"2018","journal-title":"Nurs. Clin."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11010_bib6","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/01.JIM.0000446834.90599.5d","article-title":"Epidemiology and comorbidities of polycystic ovary syndrome in an indigent population","volume":"62","author":"Sirmans","year":"2014","journal-title":"J.\u00a0Invest. Med. : the official publication of the American Federation for Clinical Research"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11010_bib7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"issue":"36","key":"10.1016\/j.heliyon.2022.e11010_bib8","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.2174\/1381612822666160720151243","article-title":"Hirsutism in polycystic ovary syndrome: pathophysiology and management","volume":"22","author":"Spritzer","year":"2016","journal-title":"Curr. Pharmaceut. Des."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11010_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","article-title":"Polycystic ovary syndrome","volume":"132","author":"Azziz","year":"2018","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11010_bib10","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jamadermatol.2015.4498","article-title":"Cutaneous findings and systemic associations in women with polycystic ovary syndrome","volume":"152","author":"Schmidt","year":"2016","journal-title":"JAMA dermatology"},{"key":"10.1016\/j.heliyon.2022.e11010_bib11","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"1 Suppl 1","key":"10.1016\/j.heliyon.2022.e11010_bib12","first-page":"s7","article-title":"Advances in the understanding of the pathogenesis of inflammatory acne","volume":"15","author":"Kircik","year":"2016","journal-title":"J.\u00a0Drugs Dermatol. JDD : J. Drugs Dermatol. JDD"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11010_bib13","doi-asserted-by":"crossref","DOI":"10.5812\/ijem.91554","article-title":"Polycystic ovary syndrome in adolescents: challenges in diagnosis and treatment","volume":"17","author":"Ramezani Tehrani","year":"2019","journal-title":"Int. J. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11010_bib14","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.3928\/19382359-20171219-01","article-title":"Menstrual irregularities","volume":"47","author":"Foster","year":"2018","journal-title":"Pediatr. Ann."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11010_bib15","first-page":"612","article-title":"Single nucleotide polymorphisms in treatment of polycystic ovary syndrome","volume":"51","author":"Deswal","year":"2019","journal-title":"a systematic review"},{"key":"10.1016\/j.heliyon.2022.e11010_bib16","first-page":"180","article-title":"Pharmacogenetics of metformin in polycystic ovary syndrome and type 2 diabetes mellitus","volume":"73","author":"Strasser","year":"2021","journal-title":"Endocr. Abstr."},{"key":"10.1016\/j.heliyon.2022.e11010_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med."},{"issue":"11","key":"10.1016\/j.heliyon.2022.e11010_bib18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.6061\/clinics\/2015(11)09","article-title":"Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice","volume":"70","author":"Melo","year":"2015","journal-title":"Clinics"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11010_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1385\/ENDO:30:1:27","article-title":"Infertility in polycystic ovary syndrome: focus on low-dose gonadotropin treatment","volume":"30","author":"Gorry","year":"2006","journal-title":"Endocrine"},{"issue":"11","key":"10.1016\/j.heliyon.2022.e11010_bib20","first-page":"3984","article-title":"Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation","volume":"83","author":"Willis","year":"1998","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.heliyon.2022.e11010_bib21","article-title":"Changes in metabolic profile in the women with a history of PCOS-A long-term follow-up study","volume":"9","author":"Jacewicz-Swiecka","year":"2020","journal-title":"J.\u00a0Clin. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11010_bib22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/humupd\/8.3.231","article-title":"Long-term health consequences of PCOS","volume":"8","author":"Wild","year":"2002","journal-title":"Hum. Reprod. Update"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11010_bib23","first-page":"279","article-title":"Polycystic ovary syndrome and metabolic syndrome","volume":"80","author":"Ali","year":"2015","journal-title":"Ceska Gynekol."},{"key":"10.1016\/j.heliyon.2022.e11010_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diabres.2017.06.011","article-title":"Insulin and the polycystic ovary syndrome","volume":"130","author":"Macut","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.heliyon.2022.e11010_bib25","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.15318.1","article-title":"Recent advances in the understanding and management of polycystic ovary syndrome","volume":"8","author":"Rocha","year":"2019","journal-title":"F1000Research"},{"key":"10.1016\/j.heliyon.2022.e11010_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10055","article-title":"Novel role for anti-Mullerian hormone in the regulation of GnRH neuron excitability and hormone secretion","volume":"7","author":"Cimino","year":"2016","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e11010_bib27","first-page":"1163","article-title":"Basic infertility including polycystic ovary syndrome","volume":"92","author":"Brassard","year":"2008","journal-title":"Med. Clin."},{"key":"10.1016\/j.heliyon.2022.e11010_bib28","article-title":"Adiposity is associated with anovulation independent of serum free testosterone: a prospective cohort study","author":"Bloom","year":"2020","journal-title":"Paediatr. Perinat. Epidemiol."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e11010_bib29","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11010_bib30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/humrep\/dew287","article-title":"The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria?","volume":"32","author":"Wang","year":"2017","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11010_bib31","first-page":"106","article-title":"Diagnosis and treatment of polycystic ovary syndrome","volume":"94","author":"Williams","year":"2016","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.heliyon.2022.e11010_bib32","series-title":"Oligomenorrhea. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2020, StatPearls Publishing LLC.","author":"Riaz","year":"2020"},{"issue":"9","key":"10.1016\/j.heliyon.2022.e11010_bib33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.NPR.0000520832.14406.76","article-title":"Secondary amenorrhea: diagnostic approach and treatment considerations","volume":"42","author":"Pereira","year":"2017","journal-title":"Nurs. Pract."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11010_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0038-1668085","article-title":"A\u00a0summary on polycystic ovary syndrome: diagnostic criteria, prevalence, clinical manifestations, and management according to the latest international guidelines","volume":"36","author":"Neven","year":"2018","journal-title":"Semin. Reprod. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11010_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cen.13245","article-title":"PCOS remains a diagnosis of exclusion: a concise review of key endocrinopathies to exclude","volume":"86","author":"Kyritsi","year":"2017","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11010_bib36","first-page":"242","article-title":"Should subclinical hypothyroidism Be an exclusion criterion for the diagnosis of polycystic ovary syndrome?","volume":"18","author":"de-Medeiros","year":"2017","journal-title":"J.\u00a0Reproduction Infertil."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11010_bib37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1590\/0004-2730000003051","article-title":"Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances","volume":"58","author":"Spritzer","year":"2014","journal-title":"Arquivos Brasileiros Endocrinol. Metabol."},{"key":"10.1016\/j.heliyon.2022.e11010_bib38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.clinbiochem.2018.03.012","article-title":"Fertility and infertility: definition and epidemiology","volume":"62","author":"Vander Borght","year":"2018","journal-title":"Clin. Biochem."},{"issue":"9","key":"10.1016\/j.heliyon.2022.e11010_bib39","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/humrep\/dex234","article-title":"The international glossary on infertility and fertility care","volume":"32","author":"Zegers-Hochschild","year":"2017","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11010_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.33314\/jnhrc.v17i01.1827","article-title":"Determinants of infertility in couples","volume":"17","author":"Tamrakar","year":"2019","journal-title":"Journal of Nepal Health Research Council"},{"issue":"9","key":"10.1016\/j.heliyon.2022.e11010_bib41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/01.JAA.0000522130.01619.b7","article-title":"Infertility: a primer for primary care providers","volume":"30","author":"Cunningham","year":"2017","journal-title":"J.\u00a0Am. Acad. Physician Assistants : Off. J. Am. Acad. Physician Assistants (JAAPA)"},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11010_bib42","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.beem.2011.08.001","article-title":"Endocrine disorders & female infertility","volume":"25","author":"Unuane","year":"2011","journal-title":"Best Pract. Res. Clin. Endocrinol. Metabol."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11010_bib43","doi-asserted-by":"crossref","first-page":"e377","DOI":"10.1097\/AOG.0000000000003271","article-title":"Infertility workup for the women's health specialist: ACOG committee opinion, number 781","volume":"133","year":"2019","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11010_bib44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10815-017-1047-7","article-title":"Polycystic ovary syndrome throughout a woman's life","volume":"35","author":"Bellver","year":"2018","journal-title":"J.\u00a0Assist. Reprod. Genet."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11010_bib45","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/09513590.2017.1395841","article-title":"Treatment strategies for women with polycystic ovary syndrome","volume":"34","author":"Jin","year":"2018","journal-title":"Gynecol. Endocrinol."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11010_bib46","first-page":"450","article-title":"Treatment strategies for infertile women with polycystic ovary syndrome","volume":"68","author":"Vitek","year":"2016","journal-title":"Minerva Ginecol."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11010_bib47","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/humupd\/dmw025","article-title":"The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance","volume":"22","author":"Balen","year":"2016","journal-title":"Hum. Reprod. Update"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11010_bib48","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/humupd\/dmq045","article-title":"Exercise therapy in polycystic ovary syndrome: a systematic review","volume":"17","author":"Harrison","year":"2011","journal-title":"Hum. Reprod. Update"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11010_bib49","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/09513590.2017.1370644","article-title":"Therapeutic approach for metabolic disorders and infertility in women with PCOS","volume":"34","author":"Morgante","year":"2018","journal-title":"Gynecol. Endocrinol. : the official journal of the International Society of Gynecological Endocrinology"},{"issue":"8","key":"10.1016\/j.heliyon.2022.e11010_bib50","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1080\/01443610701667338","article-title":"Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management","volume":"27","author":"Farshchi","year":"2007","journal-title":"J.\u00a0Obstet. Gynaecol."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11010_bib51","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1210\/jc.2018-01143","article-title":"Saturated fat ingestion promotes lipopolysaccharide-mediated inflammation and insulin resistance in polycystic ovary syndrome","volume":"104","author":"Gonz\u00e1lez","year":"2018","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11010_bib52","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/advances\/nmaa092","article-title":"Effects of dietary glycemic index and glycemic load on cardiometabolic and reproductive profiles in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Kazemi","year":"2020","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.heliyon.2022.e11010_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.00606","article-title":"Exercise interventions in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"11","author":"Patten","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.heliyon.2022.e11010_bib54","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jad.2020.12.084","article-title":"The mental health of Chinese women with polycystic ovary syndrome is related to sleep disorders, not disease status","volume":"282","author":"Yang","year":"2021","journal-title":"J.\u00a0Affect. Disord."},{"key":"10.1016\/j.heliyon.2022.e11010_bib55","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000262524","article-title":"Role of sleep and sleep loss in hormonal release and metabolism","volume":"17","author":"Leproult","year":"2010","journal-title":"Pediatric Neuroendocrinology"},{"key":"10.1016\/j.heliyon.2022.e11010_bib56","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/NSS.S127475","article-title":"Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies","volume":"10","author":"Fernandez","year":"2018","journal-title":"Nat. Sci. Sleep"},{"key":"10.1016\/j.heliyon.2022.e11010_bib57","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bpobgyn.2016.08.001","article-title":"Ovulation induction in polycystic ovary syndrome: current options","volume":"37","author":"Legro","year":"2016","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11010_bib58","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.fertnstert.2015.03.019","article-title":"Diagnostic evaluation of the infertile female: a committee opinion","volume":"103","author":"Practice Committee of the American Society for Reproductive","year":"2015","journal-title":"Fertil. Steril."},{"issue":"12","key":"10.1016\/j.heliyon.2022.e11010_bib59","article-title":"Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome","volume":"12","author":"Brown","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e11010_bib60","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00404-018-4688-6","article-title":"Letrozole versus clomiphene citrate in polycystic ovary syndrome: a meta-analysis of randomized controlled trials","volume":"297","author":"Hu","year":"2018","journal-title":"Arch. Gynecol. Obstet."},{"issue":"11","key":"10.1016\/j.heliyon.2022.e11010_bib61","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1080\/09513590.2017.1332174","article-title":"Comparison of clomiphene citrate and letrozole for ovulation induction in women with polycystic ovary syndrome: a prospective randomized trial","volume":"33","author":"Liu","year":"2017","journal-title":"Gynecol. Endocrinol."},{"issue":"10","key":"10.1016\/j.heliyon.2022.e11010_bib62","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/aogs.13395","article-title":"Ovulation induction in polycystic ovary syndrome","volume":"97","author":"Tanbo","year":"2018","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11010_bib63","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/ajo.13051","article-title":"A\u00a0brief update on the evidence supporting the treatment of infertility in polycystic ovary syndrome","volume":"59","author":"Costello","year":"2019","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"issue":"12","key":"10.1016\/j.heliyon.2022.e11010_bib64","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3109\/09513590.2015.1096337","article-title":"Letrozole versus clomiphene citrate in polycystic ovary syndrome: systematic review and meta-analysis","volume":"31","author":"Roque","year":"2015","journal-title":"Gynecol. Endocrinol."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11010_bib65","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa1313517","article-title":"Letrozole versus clomiphene for infertility in the polycystic ovary syndrome","volume":"371","author":"Legro","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"8","key":"10.1016\/j.heliyon.2022.e11010_bib66","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/humrep\/dex227","article-title":"Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome","volume":"32","author":"Amer","year":"2017","journal-title":"Hum. Reprod."},{"issue":"9","key":"10.1016\/j.heliyon.2022.e11010_bib67","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1007\/s00125-017-4306-3","article-title":"Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome","volume":"60","author":"Sam","year":"2017","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11010_bib68","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.fertnstert.2004.02.127","article-title":"Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity","volume":"82","author":"Baillargeon","year":"2004","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11010_bib69","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejogrb.2005.05.010","article-title":"Predictive value of glucose\u2013insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?","volume":"123","author":"\u00d6nalan","year":"2005","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11010_bib70","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1210\/jcem.87.2.8261","article-title":"Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial","volume":"87","author":"Fleming","year":"2002","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.heliyon.2022.e11010_bib71","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","author":"Morley","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11010_bib72","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.fertnstert.2017.06.026","article-title":"Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a guideline","volume":"108","author":"Penzias","year":"2017","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.heliyon.2022.e11010_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118353","article-title":"The ameliorative effects of marjoram in dehydroepiandrosterone induced polycystic ovary syndrome in rats","volume":"261","author":"Rababa'h","year":"2020","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11010_bib74","first-page":"225","article-title":"Dose comparison and side effect profile of metformin extended release versus metformin immediate release","volume":"29","author":"Hameed","year":"2017","journal-title":"J.\u00a0Ayub Med. Coll. Abbottabad : JAMC (J. Assoc. Med. Can.)"},{"key":"10.1016\/j.heliyon.2022.e11010_bib75","article-title":"Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome","volume":"9","author":"Weiss","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11010_bib76","first-page":"CD009090","article-title":"Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome","volume":"1","author":"Bordewijk","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"13","key":"10.1016\/j.heliyon.2022.e11010_bib77","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1056\/NEJMoa1414827","article-title":"Letrozole, gonadotropin, or clomiphene for unexplained infertility","volume":"373","author":"Diamond","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e11010_bib78","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/cpt.1035","article-title":"Benefit of preemptive pharmacogenetic information on clinical outcome","volume":"103","author":"Roden","year":"2018","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"10","key":"10.1016\/j.heliyon.2022.e11010_bib79","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.2174\/1389200214666131211153933","article-title":"Pharmacogenetic variation and metformin response","volume":"14","author":"Chen","year":"2013","journal-title":"Current Drug Metabolism"},{"issue":"9","key":"10.1016\/j.heliyon.2022.e11010_bib80","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1007\/s00125-017-4306-3","article-title":"Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome","volume":"60","author":"Sam","year":"2017","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.heliyon.2022.e11010_bib81","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nrd3483","article-title":"New role for HDACs in glucose homeostasis","volume":"10","author":"Crunkhorn","year":"2011","journal-title":"Nature Reviews Drug Discovery"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11010_bib82","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1210\/jc.2007-1736","article-title":"Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene","volume":"93","author":"Legro","year":"2008","journal-title":"J.\u00a0Clinical Endocrinology Metabolism"},{"key":"10.1016\/j.heliyon.2022.e11010_bib83","series-title":"Polycystic Ovary Syndrome and Ovulation Induction","first-page":"389","author":"Yildiz","year":"2006"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11010_bib84","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.bbrc.2011.09.134","article-title":"Relevance of the OCT1 transporter to the antineoplastic effect of biguanides","volume":"414","author":"Segal","year":"2011","journal-title":"Biochemical Biophy. Res. Communi."},{"issue":"7","key":"10.1016\/j.heliyon.2022.e11010_bib85","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.3390\/ijms20071720","article-title":"Association between polymorphisms of OCT1 and metabolic response to metformin in women with polycystic ovary syndrome","volume":"20","author":"Chang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2022.e11010_bib86","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fendo.2019.00023","article-title":"Follicle stimulating hormone receptor (FSHR) polymorphisms and polycystic ovary syndrome (PCOS)","volume":"10","author":"Jsjfie","year":"2019","journal-title":"Frontiers Endocrinology"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11010_bib87","first-page":"115","article-title":"Androgen receptor gene polymorphism and polycystic ovary syndrome","volume":"120","author":"Lin","year":"2013","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11010_bib88","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1385\/ENDO:30:1:19","article-title":"The role of genes and environment in the etiology of PCOS","volume":"30","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11010_bib89","first-page":"1","article-title":"The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis","volume":"14","author":"Chaudhary","year":"2021","journal-title":"J.\u00a0Ovarian Res."},{"key":"10.1016\/j.heliyon.2022.e11010_bib90","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1186\/1472-6882-14-511","article-title":"Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo\/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings","volume":"14","author":"Arentz","year":"2014","journal-title":"BMC Compl. Alternative Med."},{"issue":"9","key":"10.1016\/j.heliyon.2022.e11010_bib91","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/ptr.5858","article-title":"Combined lifestyle and herbal medicine in overweight women with polycystic ovary syndrome (PCOS): a randomized controlled trial","volume":"31","author":"Arentz","year":"2017","journal-title":"Phytother Res."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11010_bib92","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ptr.5970","article-title":"Insulin resistance improvement by cinnamon powder in polycystic ovary syndrome: a randomized double-blind placebo controlled clinical trial","volume":"32","author":"Hajimonfarednejad","year":"2018","journal-title":"Phytother Res."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11010_bib93","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12958-018-0418-y","article-title":"The effect of cinnamon on polycystic ovary syndrome in a mouse model","volume":"16","author":"Dou","year":"2018","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11010_bib94","first-page":"556","article-title":"Cinnamon improves metabolic factors without detectable effects on adiponectin in women with polycystic ovary syndrome","volume":"27","author":"Borzoei","year":"2018","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"10.1016\/j.heliyon.2022.e11010_bib95","first-page":"265","article-title":"Traditional Indian spices and their health significance","volume":"17","author":"Krishnaswamy","year":"2008","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"10.1016\/j.heliyon.2022.e11010_bib96","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-0-12-800173-8.00003-9","article-title":"Curcumin","volume":"39","author":"Lestari","year":"2014","journal-title":"Profiles of drug substances, excipients, and related methodology"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11010_bib97","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jtcme.2016.05.005","article-title":"Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives\u2013A review","volume":"7","author":"Amalraj","year":"2017","journal-title":"Journal of traditional and complementary medicine"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11010_bib98","first-page":"352","article-title":"The effect of curcumin on TNF-\u03b1, IL-6 and CRP expression in a model of polycystic ovary syndrome as an inflammation state","volume":"18","author":"Mohammadi","year":"2017","journal-title":"J.\u00a0Reproduction Infertil."},{"issue":"9","key":"10.1016\/j.heliyon.2022.e11010_bib99","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.4103\/0366-6999.204927","article-title":"Protective effects of curcumin against sodium arsenite-induced ovarian oxidative injury in a mouse model","volume":"130","author":"Wang","year":"2017","journal-title":"Chin Med J (Engl)."},{"key":"10.1016\/j.heliyon.2022.e11010_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2019.102201","article-title":"The effects of curcumin supplementation on glycemic status, lipid profile and hs-CRP levels in overweight\/obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial","volume":"47","author":"Sohaei","year":"2019","journal-title":"Compl. Ther. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11010_bib101","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/jhn.12290","article-title":"The effect of marjoram (Origanum majorana) tea on the hormonal profile of women with polycystic ovary syndrome: a randomised controlled pilot study","volume":"29","author":"Haj-Husein","year":"2016","journal-title":"J.\u00a0Hum. Nutr. Diet."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11010_bib102","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s40199-019-00312-0","article-title":"A\u00a0comprehensive review of clinical studies with herbal medicine on polycystic ovary syndrome (PCOS)","volume":"27","author":"Moini Jazani","year":"2019","journal-title":"Daru"},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11010_bib103","first-page":"645","article-title":"Hydroalcoholic extract of flaxseed improves polycystic ovary syndrome in a rat model","volume":"21","author":"Jelodar","year":"2018","journal-title":"Iran J Basic Med Sci"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11010_bib104","article-title":"Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome","author":"Bordewijk","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"issue":"21","key":"10.1016\/j.heliyon.2022.e11010_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218147","article-title":"Molecular mechanisms of laparoscopic ovarian drilling and its therapeutic effects in polycystic ovary syndrome","volume":"21","author":"Seow","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11010_bib106","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4103\/jhrs.JHRS_161_18","article-title":"Laparoscopic ovarian drilling reduces testosterone and luteinizing hormone\/follicle-stimulating hormone ratio and improves clinical outcome in women with polycystic ovary syndrome","volume":"12","author":"Sinha","year":"2019","journal-title":"J.\u00a0Hum. Reprod. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11010_bib107","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1097\/j.pbj.0000000000000116","article-title":"Infertility management in women with polycystic ovary syndrome: a review","volume":"6","author":"Cunha","year":"2021","journal-title":"Porto Biomed J"},{"issue":"8","key":"10.1016\/j.heliyon.2022.e11010_bib108","first-page":"1399","article-title":"Effects of bariatric surgery on patients with obesity and polycystic ovary syndrome: a meta-analysis. Surgery for obesity and related diseases","volume":"17","author":"Tian","year":"2021","journal-title":"official journal of the American Society for Bariatric Surgery"},{"key":"10.1016\/j.heliyon.2022.e11010_bib109","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.metabol.2018.11.002","article-title":"Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics","volume":"92","author":"Glueck","year":"2019","journal-title":"Metab. Clin. Exp."},{"issue":"9","key":"10.1016\/j.heliyon.2022.e11010_bib110","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1016\/j.sjbs.2021.05.022","article-title":"Impact of bariatric surgery on androgen profile and ovarian volume in obese polycystic ovary syndrome patients with infertility","volume":"28","author":"Ezzat","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.heliyon.2022.e11010_bib111","series-title":"Intrauterine Insemination. Infertility in Women with Polycystic Ovary Syndrome: Springer","first-page":"249","author":"van Wely","year":"2018"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11010_bib112","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.fertnstert.2017.08.022","article-title":"Mild stimulation for in vitro fertilization","volume":"108","author":"Nargund","year":"2017","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11010_bib113","first-page":"156","article-title":"A\u00a0history of developments to improve in vitro fertilization","volume":"114","author":"Eskew","year":"2017","journal-title":"Mo. Med."},{"key":"10.1016\/j.heliyon.2022.e11010_bib114","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/bs.vh.2018.01.018","article-title":"The ovarian hyperstimulation syndrome","volume":"107","author":"Blumenfeld","year":"2018","journal-title":"Vitam. Horm."},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2022.e11010_bib115","article-title":"Prevention and management of ovarian hyperstimulation syndrome","volume":"151","author":"Nelson","year":"2017","journal-title":"Thromb. Res."},{"key":"10.1016\/j.heliyon.2022.e11010_bib116","first-page":"1","article-title":"Does COVID-19 infection influence patients\u2019 performance during IVF-ET cycle?: an observational study","author":"Orvieto","year":"2021","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.heliyon.2022.e11010_bib117","series-title":"IVF and Early Pregnancy Outcome in Recent COVID 19 Recoverees","author":"Yossef","year":"2021"},{"key":"10.1016\/j.heliyon.2022.e11010_bib118","unstructured":"Aharon D, Lederman M, Ghofranian A, Hernandez-Nieto C, Canon C, Hanley W, et\u00a0al. In Vitro Fertilization and Early Pregnancy Outcomes after Coronavirus Disease 2019 (COVID-19) Vaccination. Obstetrics & Gynecology. 9900."},{"key":"10.1016\/j.heliyon.2022.e11010_bib119","first-page":"1","article-title":"Psychological status of infertile patients who had in vitro fertilization treatment interrupted or postponed due to COVID-19 pandemic: a cross-sectional study","author":"Barra","year":"2020","journal-title":"J.\u00a0Psychosom. Obstet. Gynecol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022022988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022022988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:25:29Z","timestamp":1790353529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844022022988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":119,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2405844022022988"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e11010","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An update of polycystic ovary syndrome: causes and therapeutics options","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e11010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e11010"}}